Retina/Vitreous

Top Story

Study questions utility of topical NSAIDs to reduce already low incidence of macular edema in cataract surgery

February 17, 2017

Topical NSAID use in patients who underwent cataract surgery was associated with a reduction in the already low incidence of postoperative macular edema, according to researchers.

In the retrospective matched cohort, a total of 108,093 patients underwent cataract surgery and 89,731 met inclusion criteria between January 2007 and June 2014 at Kaiser Permanente Southern California.

Meeting News

Brolucizumab shows noninferiority to aflibercept for treatment of AMD

February 17, 2017
MIAMI — Two phase 2 studies comparing brolucizumab vs. aflibercept for the treatment of neovascular age-related macular degeneration showed comparable efficacy…
Perspectives on Glaucoma

OCT imaging of retina useful in detecting glaucoma ‘masqueraders’

February 16, 2017
Optic nerve and macular optical coherence tomography can be helpful in distinguishing between glaucoma and glaucoma masqueraders, according to researchers. Researchers…
Meeting News

OCT angiography may be used to identify biomarkers of neovascular activity

February 16, 2017
MIAMI — Several biomarkers of neovascularization in age-related macular degeneration, such as secondary small vessel branching and greater fractal dimension, can…
COPE

Diabetic Eye Disease: Screening Strategies and Imaging Devices - Number 1

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »
Video
Meeting News

VIDEO: Lampalizumab phase 3 trial progressing

Ocular Surgery News APAO Edition, January 2017
More »
Featured
Video
Meeting News

VIDEO: Lampalizumab phase 3 trial progressing

January 18, 2017
More »
In the Journals

Study questions utility of topical NSAIDs to reduce already low incidence of macular edema in cataract surgery

February 17, 2017
Topical NSAID use in patients who underwent cataract surgery was associated with a reduction in the already low incidence of postoperative macular…

Meeting News

Brolucizumab shows noninferiority to aflibercept for treatment of AMD

February 17, 2017
MIAMI — Two phase 2 studies comparing brolucizumab vs. aflibercept for the treatment of neovascular age-related macular degeneration showed…

Perspectives on Glaucoma

OCT imaging of retina useful in detecting glaucoma ‘masqueraders’

February 16, 2017
Optic nerve and macular optical coherence tomography can be helpful in distinguishing between glaucoma and glaucoma masqueraders, according to…

Meeting News

OCT angiography may be used to identify biomarkers of neovascular activity

February 16, 2017
MIAMI — Several biomarkers of neovascularization in age-related macular degeneration, such as secondary small vessel branching and greater…

What's Your Diagnosis?

Patient complains of distorted vision

Primary Care Optometry News, February 2017
Daniel Brigham, OD
A 59-year-old African American male presented with a chief complaint of distorted and blurred vision that is worse in the right eye than the left…

Meeting News

Patients with certain genetic variants are at greater risk for AMD progression

February 15, 2017
MIAMI — Age, phenotype characteristics and genetic variants can put patients at greater risk for progression of age-related macular…

Meeting News

Retina World Congress to represent more than 100 countries

February 14, 2017
The Retina World Congress will take place in Fort Lauderdale, Florida, from Feb. 23 to 26, with more than 900 attendees already registered and more…

Meeting News

Diet plays important role in risk of developing AMD

February 14, 2017
MIAMI — A patient’s diet influences the risk of developing age-related macular degeneration, regardless of genetics, according to a…

Video

Genentech completes enrollment in two phase 3 lampalizumab studies

February 2, 2017
Patient enrollment has been completed in two

Phase 2a begins for emixustat for macular atrophy, Stargardt’s

February 2, 2017
Acucela Inc. announced that the first patient has been enrolled in a study to evaluate its leading drug candidate, emixustat HCl, in subjects with…

More Headlines »
Advertisement
Advertisement